MedPath

Trial Comparing Early Laparoscopic Enterolysis Versus Nonoperative Management for High-grade SBO

Phase 2
Terminated
Conditions
Small Bowel Obstruction
Registration Number
NCT02692638
Lead Sponsor
Yale University
Brief Summary

The goal is to assess the appropriateness of the standard practice of a trial of nonoperative management for high grade small bowel obstruction (currently up to 72 hours based on available literature). The investigator will offer early laparoscopic enterolysis (within 24 hours of admission) as the comparator group.

Detailed Description

Small bowel obstruction is a common disorder without a clearly superior management strategy. There are an estimated 300,000 surgeries performed annually with a health care expenditure burden in excess of 2.8 billion dollars. The investigators propose a new management paradigm including early laparoscopic management.

Contemporary management of SBO includes a trial of nonoperative management (TNOM) reportedly with resolution in upwards of 70% of patients.

Although it is one of the most common diagnosis for surgical admissions, there are few prospective, clinical trials to address the question surgical timing. Additionally, there are no prospective, randomized trials comparing early laparoscopy versus TNOM for high grade SBO. The hypothesis is that early laparoscopic enterolysis will result in decreased overall complications, shorter length of stay, decreased health care cost, and lower conversion rate to open laparotomy.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
3
Inclusion Criteria
  • CT A/P showing high grade obstruction (all patients will obtain a CT A/P as per Level 1 recommendations based on EAST practice guidelines) .

  • High grade bowel obstruction is defined as:

    • Transition point
    • Distal small collapse with proximal dilatation
    • Small bowel feces sign
    • 50% difference in caliber change between proximal dilated bowel and distal decompressed bowel
    • Intra-abdominal free fluid without clinical signs of ischemia
Exclusion Criteria
  • Hemodynamic instability (SBP<90)
  • Peritonitis
  • Enterocutaneous fistula
  • Cirrhosis
  • previous enterolysis (more than 1)
  • Contraindication to laparoscopic surgery
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Number of complications (per National Surgical Quality Improvement Project)2 weeks

complications counted : Superficial surgical site infection (SSI), Deep SSI, Organ space SSI, Wound disruption, pneumonia, Pulmonary embolism, ventilator days, Acute Kidney Injury (AKI), Acute renal failure (ARF), Urinary Tract Infection (UTI), Stroke, Cardiac arrest, Myocardial Infarction (MI), Sepsis, Deep vein thrombosis (DVT)

Secondary Outcome Measures
NameTimeMethod
number of subjects with unplanned return to operating roomwithin two weeks of discharge
number of subjects with hospital readmissionwithin 2 weeks of discharge
number of subjects with 30 day mortality30 days post operation
Average Length of staylength of hospital stay, Time 0 is at randomization with expected length of stay less than 3 weeks.

length, in days, of hospital stay, calculated by subtracting date of randomization from date of discharge

Average cost in dollarslength of hospital stay, Time 0 is at randomization with expected length of stay less than 3 weeks.

average cost of care of patients per arm for length of hospital stay

Trial Locations

Locations (1)

Yale New Haven Hospital

🇺🇸

New Haven, Connecticut, United States

Yale New Haven Hospital
🇺🇸New Haven, Connecticut, United States
© Copyright 2025. All Rights Reserved by MedPath